Does Indiana Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Covered, prior authorization. Wegovy is non-preferred on the Statewide Uniform Preferred Drug List since July 2025, under class-wide GLP-1 prior authorization with quantity limits

Does Indiana Medicaid cover Mounjaro or Zepbound for weight loss?

Covered, prior authorization. Zepbound is preferred on the Statewide Uniform Preferred Drug List since July 2025, under class-wide GLP-1 prior authorization with quantity limits

Medicaid coverage

Indiana: what Medicaid covers

Indiana added Wegovy, as non-preferred, and Zepbound, as preferred, to its Statewide Uniform Preferred Drug List in July 2025, both under class-wide GLP-1 prior authorization with quantity limits. Saxenda is not named in any of the state bulletins reviewed.

Checked against the primary source August 27, 2026

What Medicaid in Indiana covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Prior authorization	Wegovy is non-preferred on the Statewide Uniform Preferred Drug List since July 2025, under class-wide GLP-1 prior authorization with quantity limits Changed July 1, 2025
Tirzepatide	Prior authorization	Zepbound is preferred on the Statewide Uniform Preferred Drug List since July 2025, under class-wide GLP-1 prior authorization with quantity limits Changed July 1, 2025
Liraglutide	not checked	Saxenda is not named in the bulletins reviewed

Semaglutide Prior authorization

Wegovy is non-preferred on the Statewide Uniform Preferred Drug List since July 2025, under class-wide GLP-1 prior authorization with quantity limits

Changed July 1, 2025
Tirzepatide Prior authorization

Zepbound is preferred on the Statewide Uniform Preferred Drug List since July 2025, under class-wide GLP-1 prior authorization with quantity limits

Changed July 1, 2025
Liraglutide not checked

Saxenda is not named in the bulletins reviewed

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
IHCP Bulletin BT202572: Pharmacy updates approved by Drug Utilization Review Board May 2025
Indiana Family and Social Services Administration, Indiana Health Coverage Programs Primary text read and checked Checked August 27, 2026